Sign In   Register
x
Play video and select frame to capture or upload thumbnail
  Play   Capture Upload Own Image

Lineage Cell Therapeutics busy working on treatments relating to Dry AMD and spinal cord injury

By InnoCan Pharma in News 1st Oct, 2020 Video Duration: 00:06:52
Lineage Cell Therapeutics (NYSE AMERICAN: LCTX) CEO Brian Culley and CFO Brandi Roberts joined Steve Darling from Proactive to share details about their proprietary cell-based therapy platform. The Company is using that platform to advance a pipeline of novel candidates for the treatment of advanced dry age-related macular degeneration, spinal cord injuries, and cancer. Both Culley and Roberts discussed recent clinical developments and provided an overview of the Company’s balance sheet. Lineage will be a featured company on Proactive’s next One2One Virtual conferences.

People In This Video
No users are tagged in this video


0
0
0
0
0
0
Comments (0)
Unable to load tooltip content.

MjInvest.com